Today, the Board of Directors of Amedisys, Inc. (NASDAQ:AMED) announced a leadership change that President and Chief Executive Officer, Chris Gerard, will leave the company effective November 17, 2022, and Paul Kusserow, Chair of the Board of Directors will take over as Chief Executive Officer until a new Chief Executive Officer is identified.
In conjunction with this leadership change, Amedisys confirms its full year guidance.
“We are on track to meet the guidance range that was previously released,” said Paul Kusserow, Chairman and CEO. “We look forward to producing predictable results that will instill confidence in our shareholders.”
